Timing of Intervention for Aortic Intramural Hematoma

• Type: Article in International Scientific Journal
• Date: 2023

Authors

Vacirca A. (Author) Other; Dias-Neto M (Author) FMUP; Baghbani-Oskouei A. (Author) Other; Huang Y. (Author) Other; Tenorio E.R. (Author) Other; Estrera A. (Author) Other; Oderich G.S. (Author) Other

Journal

Title: Annals of Vascular Surgery

Vol. 94

Pages: 14-21

ISSN: 0890-5096

Publisher: Elsevier

Indexing

Scopus - 3 Citations

Other information

Authenticus ID: P-010-SCR

DOI: 10.1016/j.avsg.2022.09.041

Abstract (EN): Intramural hematoma (IMH) is one of the acute aortic syndromes along with acute aortic dissection and penetrating aortic ulcer. The three conditions can occur alone or in combination with overlapping presentation. Medical, open surgical, and endovascular treatment is tailored depending on clinical presentation, timing, and location within the aorta. Among patients who present with acute IMH affecting the ascending aorta (Type A), urgent open surgical repair is considered the primary line of treatment in patients who are suitable candidates and unstable. The management of IMH in the descending aorta and aortic arch (Type B) is similar to that applied to treat acute dissections in the same segment. Medical treatment with sequential imaging is recommended in patients with uncomplicated course, and endovascular repair is indicated in patients with rupture, persistent pain, end-organ ischemia, or rapid aortic enlargement. This review discusses the ideal timing for treatment of IMH.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 7